Core Insights - The company reported a consolidated revenue of HKD 9.452 billion for the first three quarters of 2025, representing a 10% increase compared to the same period last year [1] - The company's attributable profit decreased by 6% year-on-year to HKD 109 million [1] Segment Performance - The food biotechnology segment generated revenue of HKD 7.836 billion, an 11% increase year-on-year, but the segment profit (excluding share of associates) fell by 12% to HKD 138 million [1] - The company maintained its slaughtering operations in the Greater Bay Area, with a live pig slaughter volume of approximately 2.34 million heads, but faced a decline in operating profit due to intensified regional competition and price adjustments [1] - The market share for live pigs supplied to Hong Kong decreased to 48% from 49% year-on-year, leading to a reduction in profits from the live pig distribution business [1] - The company is expanding its food wholesale and retail operations in Hong Kong, currently operating 19 retail stores [1] - The performance of the joint venture in live pig breeding and sales slowed down due to falling pig prices in the third quarter, with the company's share of profits from associates amounting to HKD 18.91 million [1] - After accounting for the share of profits from associates, the segment profit for food biotechnology was HKD 157 million, a decrease of HKD 8.92 million or 5% year-on-year [1]

Core Viewpoint - Guangnan Group (01203) reported a 12% year-on-year increase in revenue to HKD 6.081 billion for the six months ending June 30, 2025, with a 32% increase in profit attributable to shareholders to HKD 76.207 million [1] Financial Performance - Revenue for the food biotechnology segment reached HKD 5.019 billion, accounting for 83% of the group's total revenue, representing a year-on-year increase of HKD 589 million or 13% [1] - Profit from the food biotechnology segment (excluding share of profits from associates) was HKD 91.8 million, a decrease of 5% year-on-year [1] - The performance of the joint venture in live pig farming and sales improved significantly, with the group's share of profits from associates at HKD 14.55 million, recovering from a loss of HKD 18.77 million in the previous year [1] - Including the share of profits from associates, the profit for the food biotechnology segment was HKD 106 million, an increase of HKD 28.21 million or 36% year-on-year [1] Dividend Announcement - The company proposed an interim dividend of HKD 0.025 per share [1]